Articles

1. Flow Chemistry: Scale-Up Solution For Modern API Manufacturing 2/20/2019

   Once deemed an “experts-only” approach to chemical synthesis, flow chemistry is a cost-efficient technique growing in popularity that can increase safety and flexibility and improve product quality.

2. A High Volume Process For Highly Potent (HP) Active Pharmaceutical Ingredients (APIs) 2/20/2013

   This case study demonstrates how a commercial manufacturing partnership between Alkermes Contract Pharma Services (Alkermes) and a large pharmaceutical company resulted in the establishment of a high volume process for Highly Potent (HP) Active Pharmaceutical Ingredients (APIs).

3. Outsourcing In The Pharma Industry – Experience, Expertise And Enthusiasm 6/13/2012

   2012 will be regarded by many commentators as one of the most challenging years in the pharmaceutical industry’s history, due in no small part to numerous products facing patent expirations and increased global competition.

4. Kemwell Overview 3/29/2012
   Manufacturing customers include top pharmaceutical companies – Allergan, Bayer, GSK, J&J, Pfizer, Teva, and Novartis, as well as small emerging biotech.
5. DSM's Route Scouting & Implementation of Synthetic Processes Is A Cost-effective Solution For Commercialization 3/28/2012
   DSM's cost-effective solution in route design and implementation of synthetic processes offers the capability to support emerging pharma companies with high potential and biotechs project and small molecule projects.
6. Sterile Clinical Trial Material Formulation & Filling 3/26/2012
   DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
7. Cytotoxic Formulation & Filling 3/26/2012
   DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
8. Accelerated Drug Development: The Promise Is In The Process 3/21/2012

   In 1993, the FDA issued the call to the pharmaceutical industry to streamline the drug development process from discovery to First In Man. By Jan-Olav Henck, Ph.D., Chief Scientific Officer, Aptuit LLC

9. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
   Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
10. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
    DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.